174 related articles for article (PubMed ID: 17434239)
1. Age related changes in brain metabolites observed by 1H MRS in APP/PS1 mice.
Oberg J; Spenger C; Wang FH; Andersson A; Westman E; Skoglund P; Sunnemark D; Norinder U; Klason T; Wahlund LO; Lindberg M
Neurobiol Aging; 2008 Sep; 29(9):1423-33. PubMed ID: 17434239
[TBL] [Abstract][Full Text] [Related]
2. Age-related changes in brain metabolites and cognitive function in APP/PS1 transgenic mice.
Chen SQ; Cai Q; Shen YY; Wang PJ; Teng GJ; Zhang W; Zang FC
Behav Brain Res; 2012 Nov; 235(1):1-6. PubMed ID: 22828014
[TBL] [Abstract][Full Text] [Related]
3. Regional metabolic alteration of Alzheimer's disease in mouse brain expressing mutant human APP-PS1 by 1H HR-MAS.
Woo DC; Lee SH; Lee DW; Kim SY; Kim GY; Rhim HS; Choi CB; Kim HY; Lee CU; Choe BY
Behav Brain Res; 2010 Jul; 211(1):125-31. PubMed ID: 20307581
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice.
Kandimalla KK; Wengenack TM; Curran GL; Gilles EJ; Poduslo JF
J Pharmacol Exp Ther; 2007 Aug; 322(2):541-9. PubMed ID: 17505020
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance spectroscopic analysis of Alzheimer's disease mouse brain that express mutant human APP shows altered neurochemical profile.
Dedeoglu A; Choi JK; Cormier K; Kowall NW; Jenkins BG
Brain Res; 2004 Jun; 1012(1-2):60-5. PubMed ID: 15158161
[TBL] [Abstract][Full Text] [Related]
6. Age-related decrease in stimulated glutamate release and vesicular glutamate transporters in APP/PS1 transgenic and wild-type mice.
Minkeviciene R; Ihalainen J; Malm T; Matilainen O; Keksa-Goldsteine V; Goldsteins G; Iivonen H; Leguit N; Glennon J; Koistinaho J; Banerjee P; Tanila H
J Neurochem; 2008 May; 105(3):584-94. PubMed ID: 18042177
[TBL] [Abstract][Full Text] [Related]
7. Enhanced accumulation of phosphorylated alpha-synuclein in double transgenic mice expressing mutant beta-amyloid precursor protein and presenilin-1.
Kurata T; Kawarabayashi T; Murakami T; Miyazaki K; Morimoto N; Ohta Y; Takehisa Y; Nagai M; Ikeda M; Matsubara E; Westaway D; Hyslop PS; Harigaya Y; Kamiya T; Shoji M; Abe K
J Neurosci Res; 2007 Aug; 85(10):2246-52. PubMed ID: 17526016
[TBL] [Abstract][Full Text] [Related]
8. Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease.
El Tannir El Tayara N; Delatour B; Le Cudennec C; Guégan M; Volk A; Dhenain M
Neurobiol Dis; 2006 Apr; 22(1):199-208. PubMed ID: 16337798
[TBL] [Abstract][Full Text] [Related]
9. Reduced retinal function in amyloid precursor protein-over-expressing transgenic mice via attenuating glutamate-N-methyl-d-aspartate receptor signaling.
Shimazawa M; Inokuchi Y; Okuno T; Nakajima Y; Sakaguchi G; Kato A; Oku H; Sugiyama T; Kudo T; Ikeda T; Takeda M; Hara H
J Neurochem; 2008 Oct; 107(1):279-90. PubMed ID: 18691390
[TBL] [Abstract][Full Text] [Related]
10. Reduction of hippocampal N-acetyl aspartate level in aged APP(Swe)/PS1(dE9) transgenic mice is associated with degeneration of CA3 pyramidal neurons.
Xu W; Zhan Y; Huang W; Wang X; Zhang S; Lei H
J Neurosci Res; 2010 Nov; 88(14):3155-60. PubMed ID: 20806406
[TBL] [Abstract][Full Text] [Related]
11. (1)H-MRS evaluation of therapeutic effect of neural stem cell transplantation on Alzheimer's disease in AβPP/PS1 double transgenic mice.
Chen SQ; Cai Q; Shen YY; Wang PJ; Teng GJ; Li MH; Zhang W; Zang FC
J Alzheimers Dis; 2012; 28(1):71-80. PubMed ID: 21955813
[TBL] [Abstract][Full Text] [Related]
12. Altered levels and distribution of IGF-II/M6P receptor and lysosomal enzymes in mutant APP and APP + PS1 transgenic mouse brains.
Amritraj A; Hawkes C; Phinney AL; Mount HT; Scott CD; Westaway D; Kar S
Neurobiol Aging; 2009 Jan; 30(1):54-70. PubMed ID: 17561313
[TBL] [Abstract][Full Text] [Related]
13. Increase in presenilin 1 (PS1) levels in senescence-accelerated mice (SAMP8) may indirectly impair memory by affecting amyloid precursor protein (APP) processing.
Kumar VB; Franko M; Banks WA; Kasinadhuni P; Farr SA; Vyas K; Choudhuri V; Morley JE
J Exp Biol; 2009 Feb; 212(Pt 4):494-8. PubMed ID: 19181896
[TBL] [Abstract][Full Text] [Related]
14. A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice.
Arendash GW; Jensen MT; Salem N; Hussein N; Cracchiolo J; Dickson A; Leighty R; Potter H
Neuroscience; 2007 Oct; 149(2):286-302. PubMed ID: 17904756
[TBL] [Abstract][Full Text] [Related]
15. Changes in cerebral blood volume and amyloid pathology in aged Alzheimer APP/PS1 mice on a docosahexaenoic acid (DHA) diet or cholesterol enriched Typical Western Diet (TWD).
Hooijmans CR; Rutters F; Dederen PJ; Gambarota G; Veltien A; van Groen T; Broersen LM; Lütjohann D; Heerschap A; Tanila H; Kiliaan AJ
Neurobiol Dis; 2007 Oct; 28(1):16-29. PubMed ID: 17720508
[TBL] [Abstract][Full Text] [Related]
16. Altered neurochemical profile in the McGill-R-Thy1-APP rat model of Alzheimer's disease: a longitudinal in vivo 1 H MRS study.
Nilsen LH; Melø TM; Saether O; Witter MP; Sonnewald U
J Neurochem; 2012 Nov; 123(4):532-41. PubMed ID: 22943908
[TBL] [Abstract][Full Text] [Related]
17. A transgenic rat model of Alzheimer's disease with extracellular Abeta deposition.
Flood DG; Lin YG; Lang DM; Trusko SP; Hirsch JD; Savage MJ; Scott RW; Howland DS
Neurobiol Aging; 2009 Jul; 30(7):1078-90. PubMed ID: 18053619
[TBL] [Abstract][Full Text] [Related]
18. Systematic evaluation of magnetic resonance imaging and spectroscopy techniques for imaging a transgenic model of Alzheimer's disease (AβPP/PS1).
Esteras N; Alquézar C; Bartolomé F; Antequera D; Barrios L; Carro E; Cerdán S; Martín-Requero A
J Alzheimers Dis; 2012; 30(2):337-53. PubMed ID: 22406445
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effect of Coenzyme Q10 on ischemic hemisphere in aged mice with mutations in the amyloid precursor protein.
Li G; Zou L; Jack CR; Yang Y; Yang ES
Neurobiol Aging; 2007 Jun; 28(6):877-82. PubMed ID: 16806588
[TBL] [Abstract][Full Text] [Related]
20. Characterization of in vivo MRI detectable thalamic amyloid plaques from APP/PS1 mice.
Dhenain M; El Tannir El Tayara N; Wu TD; Guégan M; Volk A; Quintana C; Delatour B
Neurobiol Aging; 2009 Jan; 30(1):41-53. PubMed ID: 17588710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]